Literature DB >> 22751910

Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC.

Shigeki Kushimoto1, Hideo Wada, Kazuo Kawasugi, Kohji Okamoto, Toshimasa Uchiyama, Yoshinobu Seki, Tsuyoshi Hatada, Hiroshi Imai, Tsutomu Nobori.   

Abstract

The generation of thrombin-antithromin (AT) complex (TAT) or soluble fibrin (SF) was prospectively compared with prothrombin fragment 1 + 2 (F1 + 2) generation in patients with disseminated intravascular coagulation (DIC). The plasma levels of TAT, SF, and F1 + 2 were significantly higher in the DIC group than in the non-DIC group. The differences in these levels between the DIC group and non-DIC group were significantly related to infections and hematopoietic tumors. There were no significant differences in the TAT/F1 + 2 ratio between DIC and non-DIC patients, but the SF/F1 + 2 ratio was significantly higher in the DIC group than the non-DIC group. The plasma AT activity was significantly higher in patients with DIC with resolution than in those without resolution, and in survivors than in nonsurvivors. These findings suggest that the ratio of TAT/thrombin is constant between the patients with and without DIC but that the ratio of fibrin formation/thrombin might increase in DIC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751910     DOI: 10.1177/1076029612451648

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  2 in total

Review 1.  Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Authors:  Hidesaku Asakura; Hoyu Takahashi; Toshimasa Uchiyama; Yutaka Eguchi; Kohji Okamoto; Kazuo Kawasugi; Seiji Madoiwa; Hideo Wada
Journal:  Thromb J       Date:  2016-09-28

2.  Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.

Authors:  Satoko Sakurai; Hideki Kato; Yoko Yoshida; Yuka Sugawara; Madoka Fujisawa; Atsushi Yasumoto; Masanori Matsumoto; Yoshihiro Fujimura; Yutaka Yatomi; Masaomi Nangaku
Journal:  J Atheroscler Thromb       Date:  2019-09-04       Impact factor: 4.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.